Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UFT/LV vs 5-FU/l-LV in Stage III Colorectal Cancer
NCT00190515Phase 3Completed
- Start
- Feb 2003
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tegafur + uracil in colorectal cancer (CRC) (2 arms). Primary endpoint: Disease-free survival at 5 years. Started Feb 2003; status: completed.
02
Drugs
tegafur + uracil
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00190515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00190515.